Fig. 6

A, B: RFS in meningioma patients stratifed by ADCp1 = 85; C, D: RFS in meningioma patients stratifed by CD8 + T cells = 0.04%
A, B: RFS in meningioma patients stratifed by ADCp1 = 85; C, D: RFS in meningioma patients stratifed by CD8 + T cells = 0.04%